Page last updated: 2024-08-21

alpha-aminopyridine and Pseudomonas Infections

alpha-aminopyridine has been researched along with Pseudomonas Infections in 12 studies

Research

Studies (12)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	9 (75.00)	24.3611
2020's	3 (25.00)	2.80

Authors

Authors	Studies
Bear, CE; Deber, CM; Laselva, O; Stone, TA	1
Doull, I	1
Mayer-Hamblett, N; VanDevanter, DR	1
Ashare, A; Barnaby, R; Berwin, B; Hampton, TH; Koeppen, K; Nymon, A; Stanton, BA	1
Adam, D; Brochiero, E; Lafayette, SL; Maillé, É; McKay, G; Messaoud, H; Nguyen, D; Ruffin, M	1
DiMango, E; Hopkins, BD; Kitur, K; Parsons, R; Prince, A; Riquelme, SA; Wolfe, AL	1
Brochiero, E; Maillé, É; Rousseau, S; Roussel, L; Ruffin, M	1
Kopp, BT; Shrestha, CL; Zhang, S	1
Fischer, AJ; Fox, C; Gates, LK; McLearn-Montz, AJ; Milavetz, F; Murry, LT; Porterfield, HS; Sabus, A; Singh, SB	1
Balfour-Lynn, IM	1
Barnaby, R; Coutermarsh, B; Hogan, D; Stanton, BA	1
Bhongir, RK; Egesten, A; Kasetty, G; Papareddy, P	1

Reviews

3 review(s) available for alpha-aminopyridine and Pseudomonas Infections

Article	Year
Cystic fibrosis 2019: Year in review. Paediatric respiratory reviews, 2020, Volume: 35 Topics: Administration, Inhalation; Aminophenols; Aminopyridines; Anti-Bacterial Agents; Azithromycin; Benzodioxoles; Carrier State; Chloride Channel Agonists; Cystic Fibrosis; Drug Combinations; Exercise; Health Services Accessibility; Healthcare Disparities; Humans; Indoles; Inflammation; Physical Therapy Modalities; Pseudomonas Infections; Pyrazoles; Pyridines; Quinolines; Quinolones; Saline Solution, Hypertonic	2020
Innovating cystic fibrosis clinical trial designs in an era of successful standard of care therapies. Current opinion in pulmonary medicine, 2017, Volume: 23, Issue:6 Topics: Aminophenols; Aminopyridines; Anti-Bacterial Agents; Benzodioxoles; Chloride Channel Agonists; Clinical Trials as Topic; Comparative Effectiveness Research; Cystic Fibrosis; Disease Progression; Drug Combinations; Humans; Pseudomonas Infections; Quinolones; Standard of Care; Treatment Outcome	2017
Clinical papers of the year 2018 - Cystic fibrosis. Paediatric respiratory reviews, 2020, Volume: 33 Topics: Administration, Inhalation; Aminophenols; Aminopyridines; Anti-Bacterial Agents; Azithromycin; Benzodioxoles; Bronchoalveolar Lavage; Bronchoalveolar Lavage Fluid; Chloride Channel Agonists; Cough; Cross Infection; Cystic Fibrosis; Disease Progression; Drug Combinations; Drug Therapy, Combination; Humans; Indoles; Lung Transplantation; Microbiological Techniques; Mycobacterium abscessus; Mycobacterium Infections, Nontuberculous; Nebulizers and Vaporizers; Proton Pump Inhibitors; Pseudomonas aeruginosa; Pseudomonas Infections; Pyrazoles; Pyridines; Pyrrolidines; Quinolones; Randomized Controlled Trials as Topic; Saline Solution, Hypertonic; Specimen Handling; Sputum; Treatment Outcome; Tuberculosis, Pulmonary	2020

Other Studies

9 other study(ies) available for alpha-aminopyridine and Pseudomonas Infections

Article	Year
Anti-Infectives Restore ORKAMBI Biomolecules, 2020, 02-19, Volume: 10, Issue:2 Topics: Aminophenols; Aminopyridines; Anti-Bacterial Agents; Antimicrobial Cationic Peptides; Benzodioxoles; Bronchi; Cell Line; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Drug Combinations; Humans; Mutation; Pseudomonas aeruginosa; Pseudomonas Infections; Quinolones; Tobramycin	2020
Lumacaftor (VX-809) restores the ability of CF macrophages to phagocytose and kill Pseudomonas aeruginosa. American journal of physiology. Lung cellular and molecular physiology, 2018, 03-01, Volume: 314, Issue:3 Topics: Aminophenols; Aminopyridines; Benzodioxoles; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Drug Combinations; Forced Expiratory Volume; Humans; Macrophages; Mutation; Phagocytosis; Pseudomonas aeruginosa; Pseudomonas Infections; Quinolones	2018
Quorum Sensing Down-Regulation Counteracts the Negative Impact of Frontiers in cellular and infection microbiology, 2017, Volume: 7 Topics: Aminopyridines; Bacterial Proteins; Benzodioxoles; Cell Line; Cells, Cultured; Child; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Down-Regulation; Epithelial Cells; Gene Expression Regulation, Bacterial; Humans; Infant; Mutation; Piperazines; Pseudomonas aeruginosa; Pseudomonas Infections; Quinazolines; Quorum Sensing; Respiratory System; Trans-Activators	2017
Cystic Fibrosis Transmembrane Conductance Regulator Attaches Tumor Suppressor PTEN to the Membrane and Promotes Anti Pseudomonas aeruginosa Immunity. Immunity, 2017, 12-19, Volume: 47, Issue:6 Topics: Aminophenols; Aminopyridines; Animals; Benzodioxoles; Cell Membrane; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Gene Expression Regulation; Humans; Mice; Mice, Inbred C57BL; Mice, Knockout; Models, Molecular; Monocytes; Phosphatidylinositol 3-Kinases; Protein Binding; Protein Conformation; Protein Transport; Proto-Oncogene Proteins c-akt; Pseudomonas aeruginosa; Pseudomonas Infections; PTEN Phosphohydrolase; Quinolones; Signal Transduction	2017
Vx-809/Vx-770 treatment reduces inflammatory response to Pseudomonas aeruginosa in primary differentiated cystic fibrosis bronchial epithelial cells. American journal of physiology. Lung cellular and molecular physiology, 2018, 04-01, Volume: 314, Issue:4 Topics: Aminophenols; Aminopyridines; Benzodioxoles; Bronchi; Cells, Cultured; Chloride Channel Agonists; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Epithelial Cells; Humans; Interleukin-8; Mutation; Pseudomonas aeruginosa; Pseudomonas Infections; Quinolones	2018
Cystic fibrosis transmembrane conductance regulator (CFTR) modulators have differential effects on cystic fibrosis macrophage function. Scientific reports, 2018, 11-20, Volume: 8, Issue:1 Topics: Adult; Aminophenols; Aminopyridines; Benzodioxoles; Case-Control Studies; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Cytokines; Drug Combinations; Female; Humans; Ion Transport; Macrophages; Male; Mutation; Pseudomonas aeruginosa; Pseudomonas Infections; Quinolones; Signal Transduction	2018
Pathogen acquisition in patients with cystic fibrosis receiving ivacaftor or lumacaftor/ivacaftor. Pediatric pulmonology, 2019, Volume: 54, Issue:8 Topics: Adolescent; Adult; Aminophenols; Aminopyridines; Benzodioxoles; Child; Child, Preschool; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Drug Combinations; Female; Humans; Male; Pseudomonas aeruginosa; Pseudomonas Infections; Quinolones; Retrospective Studies; Staphylococcal Infections; Staphylococcus aureus; Young Adult	2019
Pseudomonas aeruginosa Reduces VX-809 Stimulated F508del-CFTR Chloride Secretion by Airway Epithelial Cells. PloS one, 2015, Volume: 10, Issue:5 Topics: Aminopyridines; Benzodioxoles; Bronchi; Cell Line; Cell Membrane; Chlorides; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; DNA-Binding Proteins; Epithelial Cells; Humans; Mutation; Nuclear Proteins; Pseudomonas aeruginosa; Pseudomonas Infections; Transcription Factors	2015
Roflumilast Increases Bacterial Load and Dissemination in a Model of Pseudomononas Aeruginosa Airway Infection. The Journal of pharmacology and experimental therapeutics, 2016, Volume: 357, Issue:1 Topics: Aminopyridines; Animals; Anti-Inflammatory Agents, Non-Steroidal; Bacterial Load; Benzamides; Bronchoalveolar Lavage Fluid; Chemokines; Colony Count, Microbial; Cyclopropanes; Cytokines; Female; Leukocyte Count; Lung; Mice; Mice, Inbred BALB C; Neutrophils; Pseudomonas Infections; Pulmonary Disease, Chronic Obstructive; Respiratory Tract Infections	2016